The Technological Advancement to Engineer Next-Generation Stent-Grafts: Design, Material, and Fabrication Techniques.
Ebrahim VahabliJames MannBehzad Shiroud HeidariMichael Lawrence-BrownPaul NormanShirley JansenElena De-Juan-PardoBarry J DoylePublished in: Advanced healthcare materials (2022)
Endovascular treatment of aortic disorders has gained wide acceptance due to reduced physiological burden to the patient compared to open surgery, and ongoing stent-graft evolution has made aortic repair an option for patients with more complex anatomies. To date, commercial stent-grafts are typically developed from established production techniques with simple design structures and limited material ranges. Despite the numerous updated versions of stent-grafts by manufacturers, the reoccurrence of device-related complications raises questions about whether the current manfacturing methods are technically able to eliminate these problems. The technology trend to produce efficient medical devices, including stent-grafts and all similar implants, should eventually change direction to advanced manufacturing techniques. It is expected that through recent advancements, especially the emergence of 4D-printing and smart materials, unprecedented features can be defined for cardiovascular medical implants, like shape change and remote battery-free self-monitoring. 4D-printing technology promises adaptive functionality, a highly desirable feature enabling printed cardiovascular implants to physically transform with time to perform a programmed task. This review provides a thorough assessment of the established technologies for existing stent-grafts and provides technical commentaries on known failure modes. They then discuss the future of advanced technologies and the efforts needed to produce next-generation endovascular implants.
Keyphrases
- minimally invasive
- endovascular treatment
- mental health
- healthcare
- aortic valve
- machine learning
- heart failure
- risk factors
- pulmonary artery
- deep learning
- coronary artery disease
- acute coronary syndrome
- quality improvement
- mass spectrometry
- atrial fibrillation
- low cost
- current status
- tissue engineering
- surgical site infection